Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yehonatan Sharabi

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
The Israel Medical Association Journal : IMAJ|August 18, 2011
Pheochromocytoma: progress and challengesYehonatan Sharabi
Diabetes/Metabolism Research and Reviews|November 22, 2012
Management of the unholy trinity diabetes-obesity-hypertension (diabesotension)Yehonatan Sharabi
Harefuah|May 6, 2014
[Re-organization of internal medicine wing in hospitals: a last-ditch effort or the beginning of reform?]Yehonatan Sharabi
Hypertension (Dallas, Tex. : 1979)|May 20, 2026
Individualizing Care in Resistant Hypertension: Lessons From Renal DenervationYehonatan Sharabi
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 12, 2022
Baroreflex-sympathoneural dysfunction characterizes at-risk individuals with preclinical central Lewy body diseasesDavid S Goldstein, Yehonatan Sharabi
Brain Research|October 15, 2017
The heart of PD: Lewy body diseases as neurocardiologic disordersDavid S Goldstein, Yehonatan Sharabi
Journal of the Neurological Sciences|July 19, 2011
Mechanisms of orthostatic hypotension and supine hypertension in Parkinson diseaseYehonatan Sharabi, David S Goldstein
Harefuah|April 26, 2021
[PSEUDOPHEOCHROMOCYTOMA - AN UNCOMMON FORM OF HYPERTENSION]Yehoshuaq Shuki Leshem, Yehonatan Sharabi
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|January 12, 2023
Correction to: Baroreflex‑sympathoneural dysfunction characterizes at‑risk individuals with preclinical central Lewy body diseasesDavid S Goldstein, Yehonatan Sharabi
Circulation|January 7, 2009
Neurogenic orthostatic hypotension: a pathophysiological approachDavid S Goldstein, Yehonatan Sharabi
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
The Israel Medical Association Journal : IMAJ|August 18, 2011
Pheochromocytoma: progress and challengesYehonatan Sharabi
Diabetes/Metabolism Research and Reviews|November 22, 2012
Management of the unholy trinity diabetes-obesity-hypertension (diabesotension)Yehonatan Sharabi
Harefuah|May 6, 2014
[Re-organization of internal medicine wing in hospitals: a last-ditch effort or the beginning of reform?]Yehonatan Sharabi
Hypertension (Dallas, Tex. : 1979)|May 20, 2026
Individualizing Care in Resistant Hypertension: Lessons From Renal DenervationYehonatan Sharabi
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 12, 2022
Baroreflex-sympathoneural dysfunction characterizes at-risk individuals with preclinical central Lewy body diseasesDavid S Goldstein, Yehonatan Sharabi
Brain Research|October 15, 2017
The heart of PD: Lewy body diseases as neurocardiologic disordersDavid S Goldstein, Yehonatan Sharabi
Journal of the Neurological Sciences|July 19, 2011
Mechanisms of orthostatic hypotension and supine hypertension in Parkinson diseaseYehonatan Sharabi, David S Goldstein
Harefuah|April 26, 2021
[PSEUDOPHEOCHROMOCYTOMA - AN UNCOMMON FORM OF HYPERTENSION]Yehoshuaq Shuki Leshem, Yehonatan Sharabi
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|January 12, 2023
Correction to: Baroreflex‑sympathoneural dysfunction characterizes at‑risk individuals with preclinical central Lewy body diseasesDavid S Goldstein, Yehonatan Sharabi
Circulation|January 7, 2009
Neurogenic orthostatic hypotension: a pathophysiological approachDavid S Goldstein, Yehonatan Sharabi
Pageof 12